Mechanistically, the aberrant expression and activation of TAZ in pancreatic cancer cells was due to suppression of Merlin expression, which was a positive upstream regulator of the Hippo pathway, and the oncogenic function of TAZ in pancreatic cancer was mediated by the TEAD family transcription factors. The gene discussed is NF2; the disease is pancreatic neoplasm.